BRENT L LARSON Insider Trading $NAVB NAVIDEA BIOPHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BRENT L LARSON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BRENT L LARSON. BRENT L LARSON is SVP, CFO, Treas & Secy in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB) and VP Finance and CFO in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB).
BRENT L LARSON in NAVIDEA BIOPHARMACEUTICALS, INC.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of BRENT L LARSON: SVP, CFO, Treas & Secy, VP Finance and CFO
Holdings: 220,588 shares
Current Value: $114,706
Latest Transaction: Feb 22 2012
$NAVB Market Capitalization: $77.59M
$NAVB Previous Close: $0.52
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BRENT L LARSON in NAVIDEA BIOPHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 22 2012 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | SVP, CFO, Treas & S ... | Option Exercise | A | 3.28 | 88,000 | 288,640 | 88,000 | |
| Nov 02 2011 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | SVP, CFO, Treas & S ... | Option Exercise | M | 0.13 | 30,000 | 3,900 | 0 | |
| Nov 02 2011 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | SVP, CFO, Treas & S ... | Option Exercise | M | 0.14 | 40,000 | 5,600 | 0 | |
| Nov 02 2011 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | SVP, CFO, Treas & S ... | Option Exercise | M | 0.42 | 50,000 | 21,000 | 0 | |
| Nov 02 2011 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | SVP, CFO, Treas & S ... | Payment of Exercise | F | 2.84 | 41,824 | 118,780 | 220,588 | 262.4 K to 220.6 K (-15.94 %) |
| Nov 02 2011 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | SVP, CFO, Treas & S ... | Sell | S | 2.75 | 12,500 | 34,375 | 262,412 | 274.9 K to 262.4 K (-4.55 %) |
| Nov 02 2011 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | SVP, CFO, Treas & S ... | Buy | M | 0.13 | 30,000 | 3,900 | 274,912 | 244.9 K to 274.9 K (+12.25 %) |
| Nov 02 2011 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | SVP, CFO, Treas & S ... | Buy | M | 0.14 | 40,000 | 5,600 | 244,912 | 204.9 K to 244.9 K (+19.52 %) |
| Nov 02 2011 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | SVP, CFO, Treas & S ... | Buy | M | 0.42 | 50,000 | 21,000 | 204,912 | 154.9 K to 204.9 K (+32.28 %) |
| Dec 22 2010 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Option Exercise | A | 1.90 | 95,000 | 180,500 | 95,000 | |
| Dec 16 2010 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Option Exercise | M | 0.41 | 60,000 | 24,600 | 0 | |
| Dec 16 2010 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Payment of Exercise | F | 1.97 | 28,380 | 55,909 | 154,912 | 183.3 K to 154.9 K (-15.48 %) |
| Dec 16 2010 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Buy | M | 0.41 | 60,000 | 24,600 | 183,292 | 123.3 K to 183.3 K (+48.66 %) |
| Nov 03 2009 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Option Exercise | A | 1.10 | 75,000 | 82,500 | 75,000 | |
| Oct 23 2009 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Option Exercise | M | 0.50 | 60,000 | 30,000 | 0 | |
| Oct 23 2009 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Payment of Exercise | F | 1.20 | 36,708 | 44,050 | 123,292 | 160 K to 123.3 K (-22.94 %) |
| Oct 23 2009 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Buy | M | 0.50 | 60,000 | 30,000 | 160,000 | 100 K to 160 K (+60.00 %) |
| Jan 07 2009 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Option Exercise | A | 0.59 | 25,000 | 14,750 | 25,000 |
Page: 1